Compare AMRX & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | HCC |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Coal Mining |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.3B |
| IPO Year | N/A | 2017 |
| Metric | AMRX | HCC |
|---|---|---|
| Price | $11.98 | $80.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $13.25 | ★ $73.50 |
| AVG Volume (30 Days) | ★ 1.7M | 689.4K |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.02 | ★ 0.67 |
| Revenue | ★ $2,934,959,000.00 | $1,224,320,000.00 |
| Revenue This Year | $9.99 | N/A |
| Revenue Next Year | $6.67 | $46.92 |
| P/E Ratio | $745.76 | ★ $120.84 |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $6.69 | $38.00 |
| 52 Week High | $12.68 | $85.86 |
| Indicator | AMRX | HCC |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 59.48 |
| Support Level | $11.83 | $78.00 |
| Resistance Level | $12.25 | $84.77 |
| Average True Range (ATR) | 0.33 | 3.00 |
| MACD | -0.08 | -0.15 |
| Stochastic Oscillator | 44.31 | 70.40 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.